2006

• Founded in Shanghai

2007

• Entered the field of Cardiology Intervention

2008

• Entered international market

2010

• Expanded into American Market

• Obtained Molding & Automation capability (Acquired INT Automation)

• Accessed to high-tech enterprise certification

2011

• Entered the field of Orthopedics
  

2015

• Completed Shareholding Reform

2016

Launched industry park in Zhuhai, Guangdong

2017

• Achieved "little giant" firm in Shanghai

2018

Entered fields in:

• Peripheral Implant 

• Neuro Intervention 

• CDMO

2019

• Listed on the HK main board (HK.1501)

• Established HK.INT

• Entered the field of  Cardiac Valve Implant

2020

• Specialized in Absorbable Magnesium

2021

• Entered the field of Urology

• Launched industry park in Shandong

• Established Domestic Sales Platform

2022

Entered fields in:

• Regenerative Aesthetics

• Focused Ultrasound Therapy

2023

• Rebranded to INT Medical